ImmunityBio Competitors and Similar CompaniesClear all
ImmunityBio's competitors and similar companies include Sonnet BioTherapeutics.
 ImmunityBio ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. |  Sonnet BioTherapeutics Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company. | |
Founding Date | Founding Date 2014 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Culver City, US HQ San Diego, US Woburn, US | Locations Princeton, US HQ |
Employees | Employees 16116% increase | Employees 12 |
Valuation ($) | Valuation ($) 4.3 b | Valuation ($) 2.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) $113.3m (FY, 2025) | Revenue (est.) $1m (FY, 2025) |
Net income | Net income ($351.5m) (FY, 2025) | Net income ($16m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Sonnet BioTherapeutics
HQ
Princeton, US
Employees
12
Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company.
View company